Read more

July 29, 2024
1 min read
Save

Top in cardiology: Benefits of vitamin A, weight-loss surgery in those with heart failure

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

A cross-sectional study revealed that increased vitamin A intake may improve depressive symptoms in patients with heart failure.

Daily vitamin A intake of 731.38 µg or more was significantly associated with reduced odds of depressive symptoms, according to researchers in China.

Heart failure_Adobe Stock_192824687
Researchers found that daily vitamin A intake of 731.38 µg or more reduced the risk for depressive symptoms in patients with heart failure. Image: Adobe Stock

“Vitamin A acts as an antioxidant, protecting against oxidative damage and reducing inflammation by inhibiting the production of pro-inflammatory cytokines,” they wrote. “By mitigating these processes, vitamin A may contribute to reduce the incidence of depression in [patients with heart failure].”

It was the top story in cardiology last week.

In another top story, researchers found that weight-loss surgery led to improved clinical outcomes in patients with heart failure and obesity. At 24 months, patients had reductions in BMI and HbA1c and relied less on diuretics.

Read these and more top stories in cardiology below:

Vitamin A intake may improve depressive symptoms in people with heart failure

Increased vitamin A intake may play a role in reducing depressive symptoms in patients with heart failure, according to a cross-sectional study published in ESC: Heart Failure. Read more.

Weight-loss surgery appears to benefit patients with heart failure, obesity

In a single-center cohort of patients with heart failure and obesity, weight-loss surgery led to improved clinical outcomes including reduced BMI and HbA1c and less reliance on diuretics, researchers reported. Read more.

Q&A: New initiative to address CKM syndrome, affecting millions in the US

In October 2023, the American Heart Association unveiled the term cardiovascular-kidney-metabolic syndrome to reflect the connection between metabolic and renal conditions associated with risk for heart disease. Read more.

Tackling medication nonadherence to improve heart failure management and prognosis

Medication adherence, the extent to which an individual’s behavior corresponds to a health care provider’s recommendations, remains an unaddressed challenge in health care. Four experts in pharmacology discussed how a “shared approach” using multiple strategies can improve medication adherence and outcomes in patients with heart failure. Read more.

Treating obesity can prevent, delay consequences of hypertension

The disease of obesity often brings cardiometabolic consequences, including hypertension, which remains the most potent and predictive risk factor for cardiovascular disease. Read more.